Procedural Sedation

• CLINICAL_TRIALS trial_result · 2024-03-01
  Clinical Trial Update: Dexmedetomidine and Midazolam Nebulization as Sedation During Cesarean Delivery in Pre-eclampsia [Phase 2]

  Phase 2 clinical trial evaluating dexmedetomidine and midazolam nebulization for sedation during cesarean delivery in pre-eclampsia.

• CLINICAL_TRIALS withdrawal · 2023-03-24
  Clinical Trial Update: INK Feasibility Study [Phase 3]

  A Phase 3 feasibility trial for INK in procedural sedation was withdrawn.

• CLINICAL_TRIALS trial_result · 2021-02-09
  Clinical Trial Update: Ketofol Versus Fenofol as Procedural Sedation for Carpal Tunnel Release [Phase 1, Phase 2]

  Clinical trial updates comparing ketofol to fenofol for procedural sedation during carpal tunnel release across Phase 1 and Phase 2.

• CLINICAL_TRIALS trial_result · 2021-01-15
  Clinical Trial Update: The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders [Phase 2]

  Phase 2 trial assessing dexmedetomidine for EEG sedation in children with behavioral disorders has completed with results posted.

• CLINICAL_TRIALS trial_result · 2020-03-19
  Clinical Trial Update: Inhaled Nitrous Oxide for the Prevention of Emergence Reaction During Ketamine Administration in Adults, a Pilot Study [NA]

  Pilot study evaluating inhaled nitrous oxide to prevent emergence reaction during ketamine administration in adults.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-09-12
  Clinical Trial Update: Pharmacological Characteristics of Intranasally Given Dexmedetomidine in Paediatric Patients [Phase 4]

  Phase 4 clinical trial examining pharmacological characteristics of intranasal dexmedetomidine for procedural sedation in pediatric patients…

• FDA approval · 2017-12-22
  FDA Approved: PROPOFOL — Supplemental Application (Sagent Pharmaceuticals)

  FDA approved a supplemental application for propofol from Sagent Pharmaceuticals, indicating an expanded or updated regulatory approval for …

• FDA approval · 2016-07-05
  FDA Approved: PROPOFOL — Supplemental Application (Sagent Pharmaceuticals)

  FDA approved a supplemental application for Propofol filed by Sagent Pharmaceuticals (ANDA075102).

• FDA approval · 2008-08-12
  FDA Approved: PROPOFOL — Supplemental Application (Hospira, Inc.)

  FDA approved Hospira's supplemental application for Propofol for use as an anesthetic/sedative agent.